Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2004Cancer Control

Considerations for Targeting Malignant Stem Cells in Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

MGMónica L. GuzmánNewYork–Presbyterian HospitalCJCraig T. JordanUniversity of Colorado Anschutz Medical Campus

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Guzmán et al. (2004) studied this question.

synapsesocial.com/papers/6a1776644f2b3115b01294a2https://doi.org/10.1177/107327480401100216
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia2001 · 312 citations
  2. 2Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.1992 · 167 citations
  3. 3Stem Cells in the Central Nervous System1997 · 1,477 citations
  4. 4Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells2001 · 768 citations